Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Diamond Biotechnology Co., Ltd (6815:TWSE), powered by AI.
Diamond Biotechnology Co., Ltd is currently trading at $31.05. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Diamond Biotechnology Co., Ltd on Alpha Lenz.
View Diamond Biotechnology Co., Ltd's valuation metrics on Alpha Lenz.
“Diamond Biotechnology Co., Ltd's ROE is -12.1%. Explore profitability and growth together.”
Ask for details →Diamond Biotechnology Co., Ltd is a healthcare company specializing in the research, development, manufacture, and sale of medical equipment and skincare products. Founded in 2014 and headquartered in Taipei, the company operates across both domestic and international markets, offering innovative skincare solutions under the Timera and Diamond Beauty brands as well as leasing medical devices. Its product portfolio includes facial masks, lotions, creams, essences, and specialized equipment such as sonic wave and radio wave devices, frozen fat reduction machines, and micro-plastic surgery consumables like botulinum and collagen injections—all aimed at improving skin health and aesthetic outcomes. In addition to product sales, Diamond Biotechnology provides consulting services in medical beauty management and leases specialized equipment to clinics and industry professionals. Positioned within the healthcare sector and medical equipment industry, the company plays a crucial role in enhancing personal care standards and supporting medical practitioners with advanced technology solutions. With sustained revenue growth and a diversified product lineup, Diamond Biotechnology Co., Ltd contributes significantly to the development and modernization of medical aesthetics and skin care in Taiwan and abroad.
“Diamond Biotechnology Co., Ltd's ROE is -12.1%. Explore profitability and growth together.”
Ask for details →Diamond Biotechnology Co., Ltd (ticker: 6815) is a company listed on TWSE in the Healthcare sector (Medical Devices).
The current price is 31.05 with a P/E ratio of -x and P/B of -x.
ROE is -12.07% and operating margin is -14.79%. Annual revenue is $501M.